Glycaemic control eases economic burden of diabetes mellitus Meeting report 10 February 2013 Pages: 3 - 3
Monitoring antiretroviral use crucial in resource-poor settings Comment 10 February 2013 Pages: 4 - 4
NSAID-induced GI haemorrhage in patients awaiting joint replacement Incidence study 10 February 2013 Pages: 4 - 4
Ganciclovir CMV prophylaxis cost effective post after liver transplantation Clinical study 10 February 2013 Pages: 5 - 5
Psychiatrists' ranking of antidepressants correlates with use Clinical study 10 February 2013 Pages: 5 - 5
Socioeconomic status not a factor in quality of diabetes care Clinical study 10 February 2013 Pages: 5 - 5
Notification of bloodstream infections affects LOS, charges Clinical study 10 February 2013 Pages: 7 - 7
Preventing MTCT of HIV cost effective but not straightforward in Zambia Clinical study 10 February 2013 Pages: 7 - 7
Urinary incontinence guideline intervention not a success Clinical study 10 February 2013 Pages: 7 - 7
Antipsychotic polypharmacy, comedication high in Germany Clinical study 10 February 2013 Pages: 9 - 9
Major comorbidity compounds costs in Canadians with diabetes Clinical study 10 February 2013 Pages: 9 - 9
Antipsychotic type not a factor in psychiatric resource use Clinical study 10 February 2013 Pages: 10 - 10
Hospital costs linked to age in long-term mechanical ventilation Clinical study 10 February 2013 Pages: 10 - 10
Which screen and treat strategy worth it for chlamydial infections in adolescents? Clinical study 10 February 2013 Pages: 10 - 10
Controversial healthcare reform, increased drug spending in Germany News item 10 February 2013 Pages: 11 - 11
Demand for anti-aging products to grow to $US29 billion Media release 10 February 2013 Pages: 11 - 11
Enfuvirtide, aripiprazole added to US state Special Pharmaceutical Benefits Program Media release 10 February 2013 Pages: 11 - 11